Investor Research Report on Endo International plc (NASDAQ:ENDP)


Endo International plc (NASDAQ:ENDP) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Sell” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.

Endo International plc (NASDAQ:ENDP) lost -2.61 Percent and closed its previous trading session at $7.09. The stock traded with the average Volume of 6.1 Million at the end of last session.

Endo International plc (NASDAQ:ENDP) has the Market Capitalization of 1.61 Billion. The Stock has its 52-week High of $17.99 and 52-Week Low of $ 5.77 and it touched its 52-week high on 01/04/17 and 52-Week Low on 10/27/17.

The company reported its last earnings Actual EPS of $0.91/share. While, the analyst predicted that the company could provide an EPS of $0.71/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.2/share which shows an Earnings Surprise of 28.2 Percent.

Several analysts are forecasting growth estimate of Endo International plc for the current quarter to be -65.5%. Their projections for the Next Quarter growth is -43.9 percent. While for the Next 5 years, the company could expect a growth of -16.61% per annum, whereas in the past Five years Endo International plc (NASDAQ:ENDP) showed a growth of -3.6 Percent per annum.

Sell side analysts plays vital role in buying and selling a stock where 3 analysts rated Endo International plc (NASDAQ:ENDP) as Buy, 0 analysts given Outperform signal, 5 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 0.07% where SMA50 and SMA200 are -4.9% and -29.15% respectively.

The company shows its Return on Assets (ROA) value of -38.7%. The Return on Equity (ROE) value stands at -309.7%. While it’s Return on Investment (ROI) value is -25.3%.

Endo International plc (NASDAQ:ENDP) currently has a Weekly Volatility of 5.93% percent while its Monthly Volatility is at 6.62% percent. While talking about Performance of the Stock, Endo International plc currently has a Weekly performance of -5.21%, monthly performance percentage is 13.62 percent, Quarterly performance is -17.17 percent, 6 months performance shows a percent value of -48.55% and Yearly Performance is -55.3 percent.

Company Profile:

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women’s health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.